JP2012515551A5 - - Google Patents

Download PDF

Info

Publication number
JP2012515551A5
JP2012515551A5 JP2011548095A JP2011548095A JP2012515551A5 JP 2012515551 A5 JP2012515551 A5 JP 2012515551A5 JP 2011548095 A JP2011548095 A JP 2011548095A JP 2011548095 A JP2011548095 A JP 2011548095A JP 2012515551 A5 JP2012515551 A5 JP 2012515551A5
Authority
JP
Japan
Prior art keywords
antibody
stx2
seq
fragment
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011548095A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012515551A (ja
JP5773886B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/021610 external-priority patent/WO2010085539A1/en
Publication of JP2012515551A publication Critical patent/JP2012515551A/ja
Publication of JP2012515551A5 publication Critical patent/JP2012515551A5/ja
Application granted granted Critical
Publication of JP5773886B2 publication Critical patent/JP5773886B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011548095A 2009-01-23 2010-01-21 志賀毒素タイプ2タンパク質に基づいた方法と組成物 Expired - Fee Related JP5773886B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14689209P 2009-01-23 2009-01-23
US61/146,892 2009-01-23
US21008209P 2009-03-13 2009-03-13
US61/210,082 2009-03-13
PCT/US2010/021610 WO2010085539A1 (en) 2009-01-23 2010-01-21 Methods and compositions based on shiga toxin type 2 protein

Publications (3)

Publication Number Publication Date
JP2012515551A JP2012515551A (ja) 2012-07-12
JP2012515551A5 true JP2012515551A5 (enExample) 2013-03-07
JP5773886B2 JP5773886B2 (ja) 2015-09-02

Family

ID=42356196

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011548095A Expired - Fee Related JP5773886B2 (ja) 2009-01-23 2010-01-21 志賀毒素タイプ2タンパク質に基づいた方法と組成物

Country Status (16)

Country Link
US (2) US8969529B2 (enExample)
EP (1) EP2381954B8 (enExample)
JP (1) JP5773886B2 (enExample)
KR (1) KR101832499B1 (enExample)
CN (1) CN102292098A (enExample)
AR (1) AR075047A1 (enExample)
AU (1) AU2010206800B2 (enExample)
BR (1) BRPI1007230B1 (enExample)
CA (1) CA2748873C (enExample)
CL (1) CL2011001769A1 (enExample)
ES (1) ES2614803T3 (enExample)
MX (1) MX2011007866A (enExample)
NZ (1) NZ593926A (enExample)
PE (1) PE20120425A1 (enExample)
RU (1) RU2011126896A (enExample)
WO (1) WO2010085539A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1229045A1 (en) * 2001-02-01 2002-08-07 Institut Curie Universal carrier for targeting molecules to Gb3 receptor expressing cells
CA2646319A1 (en) 2006-04-20 2007-11-01 The Henry M. Jackson Foundation For The Advancement Of Military Medicine , Incorporated Methods and compositions based on shiga toxin type 1 protein
NZ593926A (en) 2009-01-23 2013-03-28 Jackson H M Found Military Med Methods and compositions based on shiga toxin type 2 protein
US9513287B1 (en) * 2012-09-28 2016-12-06 The United States Of America, As Represented By The Secretary Of Agriculture High affinity monoclonal antibodies for detection of shiga toxin 2
US9310368B1 (en) * 2012-09-28 2016-04-12 The United States Of America, As Represented By The Secretary Of Agriculture High affinity monoclonal antibodies for detection of Shiga toxin 2 (STX2)
EP2970487B1 (en) * 2013-03-12 2020-03-11 Molecular Templates, Inc. Cytotoxic proteins comprising cell-targeting binding regions and shiga toxin a subunit regions for selective killing of specific cell types
CN103343164B (zh) * 2013-06-17 2016-05-18 武汉轻工大学 产志贺毒素大肠杆菌多重pcr检测方法、试剂盒及应用
RU2573924C2 (ru) * 2013-07-11 2016-01-27 Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран) НЕТОКСИЧНЫЙ РЕКОМБИНАНТНЫЙ ШИГА ТОКСИН 2-ГО ТИПА (Stx2)
KR20160113158A (ko) * 2014-01-27 2016-09-28 몰레큘러 템플레이츠, 인코퍼레이션. 폴리펩티드를 전달하는 mhc 클래스 i 항원결정기
US11142584B2 (en) 2014-03-11 2021-10-12 Molecular Templates, Inc. CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same
US10815469B2 (en) * 2014-06-11 2020-10-27 Molecular Templates, Inc. Cell-targeting molecules comprising protease-cleavage resistant, Shiga toxin A subunit effector polypeptides and carboxy-terminal moieties
CN104558167B (zh) * 2014-12-26 2017-12-26 江苏省疾病预防控制中心 检测i型志贺毒素双抗夹心法酶联免疫试剂盒及其应用
JP6444486B2 (ja) 2015-02-05 2018-12-26 モレキュラー テンプレーツ, インク.Molecular Templates, Inc. 志賀毒素aサブユニットエフェクター領域を含む多価cd20結合分子及びそれらの強化組成物
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
JP6771492B2 (ja) 2015-05-30 2020-10-21 モレキュラー テンプレーツ, インク.Molecular Templates, Inc. 脱免疫化された志賀毒素aサブユニット足場及びそれを含む細胞標的化分子
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
JP7075134B2 (ja) 2016-12-07 2022-05-25 モレキュラー テンプレーツ,インク. 部位特異的コンジュゲーションのための志賀毒素aサブユニットエフェクターポリペプチド、志賀毒素エフェクター足場、及び細胞標的化分子
KR102590672B1 (ko) 2017-01-25 2023-10-18 몰레큘러 템플레이츠, 인코퍼레이션. 탈면역된 시가 독소 a 서브유닛 이펙터 및 cd8+ t-세포 에피토프를 포함하는 세포-표적화 분자
MX2019009726A (es) 2018-04-17 2020-02-05 Molecular Templates Inc Moleculas con direccion hacia her2 que comprenden andamiajes de la sub-unidad a de la toxina shiga desinmunizados.
CN115856296B (zh) * 2022-12-16 2023-07-25 华北理工大学 抗志贺氏菌的单克隆抗体及其检测中的应用
CN120647752B (zh) * 2025-08-19 2025-10-28 中国人民解放军军事科学院军事医学研究院 一种抗ⅱ型志贺毒素的单克隆抗体及其相关产品和应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5164298A (en) 1988-06-24 1992-11-17 Hsc Research Development Corporation Verocytotoxin receptor assay
US6255458B1 (en) 1990-08-29 2001-07-03 Genpharm International High affinity human antibodies and human antibodies against digoxin
WO1994004679A1 (en) 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
CA2078539C (en) 1991-09-18 2005-08-02 Kenya Shitara Process for producing humanized chimera antibody
US5552144A (en) * 1992-01-22 1996-09-03 Microcarb, Inc. Immunogenic shiga-like toxin II variant mutants
US5747272A (en) 1994-02-14 1998-05-05 Henry M. Jackson Foundation For The Advancement Of Military Medicine Detection of shiga-like toxins of enterohemoragic Escherichia coli
US5968894A (en) 1994-02-22 1999-10-19 Lingwood; Clifford A. Verotoxin pharmaceutical compositions and medical treatments therewith
WO1998011229A2 (en) 1996-09-10 1998-03-19 Henry M. Jackson Foundation For The Advancement Of Military Medicine Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof
US20020160005A1 (en) 1996-11-15 2002-10-31 Trustees Of Tufts College Human neutralizing antibodies against hemolytic urmec syndrome
WO1998020903A1 (en) 1996-11-15 1998-05-22 Trustees Of Tufts College Humanized neutralizing antibodies against hemolytic uremic syndrome
US7910096B2 (en) 1996-11-15 2011-03-22 Trustees Of Tufts College Human neutralizing antibodies against hemolytic uremic syndrome
US20030170248A1 (en) 1997-12-23 2003-09-11 Jeffrey R. Stinson Humanized monoclonal antibodies that protect against shiga toxin induced disease
DE69932719T2 (de) 1998-05-20 2007-09-13 Teijin Ltd. Humanisierte Antikörper zur Erkennung von Verotoxin II sowie Zelllinie zur Herstellung derselben
WO2005011733A1 (en) * 2003-07-21 2005-02-10 Akzo Nobel N.V. Hybrid toxins comprising shiga-like toxin subunits fused to escherichia coli heat labile enterotoxin subunits and vaccines thereof
AU2004293502B2 (en) 2003-11-28 2010-12-02 National Research Council Of Canada Anticarcinoma antibodies and uses thereof
WO2005075647A1 (en) 2004-02-06 2005-08-18 Nymox Corporation Humanized antibody
CA2458084A1 (en) 2004-03-12 2005-09-12 Dalton Chemical Laboratories Inc. Novel process for octreotide synthesis
WO2006091677A1 (en) 2005-02-22 2006-08-31 Jean Gariepy Yeast strains expressing ribosome-inactivating protein domain and method of using same
ES2532985T3 (es) * 2006-02-16 2015-04-06 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Proteínas quiméricas de toxoide de Shiga
CA2646319A1 (en) 2006-04-20 2007-11-01 The Henry M. Jackson Foundation For The Advancement Of Military Medicine , Incorporated Methods and compositions based on shiga toxin type 1 protein
JP2009538916A (ja) 2006-05-31 2009-11-12 タリオン ファーマシューティカルズ インコーポレーテッド 志賀毒素関連病状を治療するための方法、組成物、およびキット
US20090258010A1 (en) 2006-05-31 2009-10-15 Thallion Pharmaceuticals, Inc. Methods, compositions, and kits for treating shiga toxin associated conditions
BRPI0720647A2 (pt) 2006-12-29 2014-01-14 Osprey Pharmaceuticals Usa Inc Processos de seleção e produção de toxinas modificadas, conjugados contendo toxinas modificadas e usos dos mesmos
EP2207793A2 (en) 2007-10-08 2010-07-21 Rutgers, The State University Nontoxic shiga-like toxin mutant compositions and methods
CN101314616B (zh) 2008-05-30 2011-05-11 中国人民解放军第三军医大学 肠出血性大肠杆菌o157:h7志贺毒素ⅱb表位肽及其应用
EP2344646A2 (en) * 2008-09-12 2011-07-20 Scarab Genomics, LLC Clean genome bactofection
NZ593926A (en) 2009-01-23 2013-03-28 Jackson H M Found Military Med Methods and compositions based on shiga toxin type 2 protein

Similar Documents

Publication Publication Date Title
JP2012515551A5 (enExample)
RU2011126896A (ru) Композиция и полипептид для стимулирования иммунологической реакции на шига токсин 2 типа
JP2009536818A5 (enExample)
JP6643454B2 (ja) Mdr大腸菌特異的抗体
CN102365097A (zh) 艰难梭菌毒素的抗体
AU2013251165A1 (en) Cross-reactive Staphylococcus aureus antibody
WO2006084467A1 (en) Surface-located streptococcus pneumoniae polypeptides
CN114729033A (zh) 抗α-溶血素的抗体及其应用
WO2016155605A1 (zh) 肺炎链球菌蛋白抗原及其制备方法和应用
JP2017505758A (ja) 黄色ブドウ球菌のlukgh(lukab)毒素に対する抗体及び抗体配列
WO2016154491A1 (en) Binding moieties for biofilm remediation
AU2008272087B2 (en) Pseudomonas aeruginosa outer membrane protein PA4710
WO2023035272A1 (zh) 一种il17抗体及其制备方法和应用
EP2528939B1 (en) Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same
CN103819557A (zh) 一种阪崎肠杆菌OmpA多克隆抗体及其制备方法与应用
ES2358804T3 (es) Polipéptidos de campylobacter jejuni ubicados en superficie.
CN103319593B (zh) 一种抗StxII单克隆抗体
Albert et al. In vitro spleen cell cytokine responses of adult mice immunized with a recombinant PorA (major outer membrane protein [MOMP]) from Campylobacter jejuni
CN103724413A (zh) 旋毛虫副肌球蛋白b细胞抗原表位8a1及其应用
Tiels et al. Monoclonal antibodies reveal a weak interaction between the F18 fimbrial adhesin FedF and the major subunit FedA
Li et al. Mimotopes selected with a neutralizing antibody against urease B from Helicobacter pylori induce enzyme inhibitory antibodies in mice upon vaccination
CN108484765B (zh) 一种抗人α-防御素-1单克隆抗体及其应用
KR101309485B1 (ko) 비브리오 패혈증균 알티엑스에이원에 특이적인 단일클론항체, 이를 분비하는 하이브리도마 및 이를 포함하는 진단키트
Meinke et al. Immunological fingerprinting of group B streptococci: from circulating human antibodies to protective antigens
CN116120410A (zh) 一种结核分枝杆菌蛋白多肽及其应用